Showing results (181-190 of 199) with videos related to

Sort By:
Pageof 20
Joint Bone Spine|August 7, 2020
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEAFlorenzo Iannone, Ennio G Favalli, Roberto Caporali, et al.
Annals of the Rheumatic Diseases|February 26, 2020
Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM)Sofia Ramiro, Robert Bm Landewé, Désirée van der Heijde, et al.
The Journal of Rheumatology|September 3, 2019
Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RAWalter P Maksymowych, Oliver FitzGerald, Mikkel Østergaard, et al.
Nature Medicine|July 1, 2020
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritisStefano Alivernini, Lucy MacDonald, Aziza Elmesmari, et al.
Clinical and Experimental Rheumatology|November 30, 2017
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritisMassimo Galli, Spinello Antinori, Fabiola Atzeni, et al.
The Journal of Rheumatology|September 17, 2019
Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM CohortAlexandre Sepriano, Sofia Ramiro, Oliver FitzGerald, et al.
Annals of the Rheumatic Diseases|October 2, 2020
EULAR definition of difficult-to-treat rheumatoid arthritisGyörgy Nagy, Nadia Mt Roodenrijs, Paco Mj Welsing, et al.
Annals of the Rheumatic Diseases|August 19, 2021
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritisGyörgy Nagy, Nadia M T Roodenrijs, Paco M J Welsing, et al.
Rheumatology (Oxford, England)|July 5, 2014
Validation of the classification criteria for cryoglobulinaemic vasculitisLuca Quartuccio, Miriam Isola, Laura Corazza, et al.
Annals of the Rheumatic Diseases|November 23, 2012
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditionsJosef S Smolen, Monika M Schoels, Norihiro Nishimoto, et al.
Pageof 20